---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-175514"
form_type: "8-K"
ticker: "GRTX"
cik: "0001563577"
company_name: "Galera Therapeutics, Inc."
filed_at: "2022-06-16T23:59:59+00:00"
generated_at: "2026-06-25T01:15:56.270192+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Galera Therapeutics stockholders elect two Class III directors, ratify KPMG as auditor

## Summary
- Dr. Emmett Cunningham and Dr. J. Mel Sorensen elected as Class III directors with ~10.6M and ~10.7M votes for, respectively.
- KPMG LLP ratified as independent auditor for FY2022 with 17,167,149 votes for, 46,053 against, and 9,939 abstained.
- Approximately 64.21% of outstanding shares (17,223,141) were present or represented at the annual meeting.

## SEC filing metadata
- accession: 0001193125-22-175514
- form_type: 8-K
- ticker: GRTX
- cik: 0001563577
- company_name: Galera Therapeutics, Inc.
- filed_at: 2022-06-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563577/000119312522175514/0001193125-22-175514-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563577/000119312522175514/d315061d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-175514
- JSON: https://secwatch.observer/filing/0001193125-22-175514.json
- Plain text: https://secwatch.observer/filing/0001193125-22-175514.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.